Alltracel 2006

alimo

this is rubbish. I've been in for years and only seen my investment eroded. 'Get rich quick' - I'll be lucky to get even in my lifetime and I'm not the only one in that position.

'Surely if AXA...' etc - on average fund managers have no more clue than anybody else. That's why all the stats say we're better off putting our money with index trackers rather than with actively managed funds. Just about every share on AIM was floated with support from institutions - what proportion then sank like a stone? I've got personal experience with quite a few (bprg, loq, flx, etc...) and I can assure you the institutions lost a fortune in every case.

'The biggest bargain' is again just wishful thinking. Have you looked at ada - trading profitably, big deals in the pipeline, and shares available for the price of their cash? What about loq - now turned round, looking to substantial profit next year, and undervalued by at least 100% on known figures? I can give you more if you want. In fact 50% of the shares on AIM can probably make a legitimate claim to being a bargain.

AP at the moment is a punt rather than an attractive long-term investment. Either the cholesterol lowering additive works and they can sign a big deal, or it does not, in which case there's no point in buying a high risk AIM stock for the sort of returns you'd get from the footsie.

I have a substantial investment in AP, but I am very conscious that I am making one of the great mistakes of high-tech investors - hanging on because I don't want to be out when the big deal comes along. They rarely do, and in the meanwhile losses could be staunched, and profits made elsewhere.

I think you need to be a little more realistic about prospects here.